Hoffman-La Roche Herceptin Product Recall (2020-06-27)
- Starting date:
- June 27, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs, Biologic/vaccine
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-73443
Last updated: 2020-06-27
Summary
-
Product:
A. Perjeta-Herceptin Kit Powder for solution (Combo pack); B. Herceptin 440 mg/vial powder for solution
Reason
Affected lots may contain the presence of glass particulates.
Depth of distribution
Wholesalers, Healthcare establishments
Affected products
A. Perjeta-Herceptin Kit Powder for solution (Combo pack)
DIN, NPN, DIN-HIM
DIN 02405024
Dosage form
Kit, Powder For Solution, Solution
Strength
Pertuzumab 420 mg/14 mL
Trastuzumab 440 mg/vial
Lot or serial number
H0379B19
Companies
- Recalling Firm
-
Hoffmann-La Roche Limited
7070 Mississauga Road
Mississauga
L5N 5M8
Ontario
CANADA
- Marketing Authorization Holder
-
Hoffmann-La Roche Limited
7070 Mississauga Road
Mississauga
L5N 5M8
Ontario
CANADA
B. Herceptin 440 mg/vial powder for solution
DIN, NPN, DIN-HIM
DIN 02240692
Dosage form
Powder for solution
Strength
Trastuzumab 440 mg/vial
Lot or serial number
N3928B01
Companies
- Recalling Firm
-
Hoffmann-La Roche Limited
7070 Mississauga Road
Mississauga
L5N 5M8
Ontario
CANADA
- Marketing Authorization Holder
-
Hoffmann-La Roche Limited
7070 Mississauga Road
Mississauga
L5N 5M8
Ontario
CANADA